Latest News

FIRST PATIENT TREATED IN GLOBAL STRATEGIC COLLABORATION WITH MEDTRONIC 40-site pilot program across US, UK and Europe aims to introduce cutting edge AI solutions into the clinical environment to improve patient care and efficiency Cydar Maps used to successfully treat...

We are delighted that Frimley Health NHS Foundation Trust has randomised its first patient in the ARIA Study with Mr David Gerrard as Principal Investigator!! Hear about the importance of the ARIA Study for the NHS from Mr David Gerrard below. The ARIA Study is a...

We are delighted to announce Sarasota Memorial Health Care System has successfully adopted Cydar Maps into their cutting-edge healthcare practice! We extend our thanks to Dr. Edwards and outstanding team for selecting Cydar Maps to elevate their surgical capabilities...

We are delighted that Brighton & Sussex University Hospitals NHS Trust has randomised its first patient in the ARIA Study with Professor Syed Waquar Yusufas as Principal Investigator!! The ARIA Study is a randomised controlled trial to assess the clinical,...

We are delighted to announce that Ochsner Health has treated its first patient using Cydar Maps!! Dr Brinster and his team successfully performed their first EVAR case with the assistance and power of cloud-based AI. Thank you to Dr Clayton Brinster, MD, FACS and the...

Appointment to support Company’s ambitious growth strategy to create value across its platform Follows a transformative 2022 having expanded the Cydar Maps product to provide a compelling solution for image guided minimally invasive endovascular procedures and signed...

Successful fundraising led by Pembroke VCT and Downing Healthcare Ventures Proceeds will enable the Company to rapidly scale-up the commercial roll-out of its 3D AI surgical maps product and continue to advance its plans to create value across its innovative...

We are delighted that Leeds Teaching Hospitals NHS Trust has randomised its first patient in the ARIA Study with Mrs Rosie Darwood as Principal Investigator!! The ARIA Study is a randomised controlled trial to assess the #clinical, technical and cost-effectiveness of...

Cydar Medical, a global, cloud-based surgical software company, announces that Alastair Harvey has been appointed in the newly created position of Chief Commercial Officer Cydar Medical, a global, cloud-based surgical software company, announces that Alastair Harvey...

Cydar Medical and King’s College London Initiates Randomized Controlled Trial of Cydar Maps Cambridge, United Kingdom - Cydar Medical, in partnership with King’s College London, has today announced it has initiated the ARIA Study: a randomised controlled trial to...